BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549:BRAF Fusion Variants

Por Lin, Alex, Rodriguez, Fausto J., Karajannis, Matthias A., Williams, Susan C., Legault, Genevieve, Zagzag, David, Burger, Peter C., Allen, Jeffrey C., Eberhart, Charles G., Bar, Eli E.
Publicado no J Neuropathol Exp Neurol (2012)

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

Por Karajannis, Matthias A., Legault, Geneviève, Hagiwara, Mari, Ballas, Marc S., Brown, Krysten, Nusbaum, Annette O., Hochman, Tsivia, Goldberg, Judith D., Koch, Kevin M., Golfinos, John G., Roland, J. Thomas, Allen, Jeffrey C.
Publicado em 2012

Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas

Por Karajannis, Matthias A., Legault, Geneviève, Hagiwara, Mari, Giancotti, Filippo G., Filatov, Alexander, Derman, Anna, Hochman, Tsivia, Goldberg, Judith D., Vega, Emilio, Wisoff, Jeffrey H., Golfinos, John G., Merkelson, Amanda, Roland, J. Thomas, Allen, Jeffrey C.
Publicado em 2014

Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas

Por Karajannis, Matthias A., Legault, Geneviève, Fisher, Michael J., Milla, Sarah S., Cohen, Kenneth J., Wisoff, Jeffrey H., Harter, David H., Goldberg, Judith D., Hochman, Tsivia, Merkelson, Amanda, Bloom, Michael C., Sievert, Angela J., Resnick, Adam C., Dhall, Girish, Jones, David T. W., Korshunov, Andrey, Pfister, Stefan M., Eberhart, Charles G., Zagzag, David, Allen, Jeffrey C.
Publicado em 2014